EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology

American Journal of Gastroenterology

Volumn 99, Issue 1, 2004, Pages 45-51

  Fritscher Ravens, Annette ^a   Broering, D C ^b   Knoefel, W T ^b   Rogiers, X ^b   Swain, P ^b   Thonke, F ^b   Bobrowski, C ^b   Topalidis, T ^b   Soehendra, N ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; BILE DUCT CARCINOMA; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER HILUS; MALE; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; SURGICAL APPROACH; SURGICAL RISK; BILE DUCT TUMOR; CYTODIAGNOSIS; INTRAHEPATIC BILE DUCT; MIDDLE AGED; NEEDLE BIOPSY; PROSPECTIVE STUDY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY, FINE-NEEDLE; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CYTODIAGNOSIS; ENDOSONOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 1542703022     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1572-0241.2003.04006.x     Document Type: Article

References (28)

1. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17.
2. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-19.
3. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663-71.
4. Havlik R, Sbisa E, Tullo A, et al. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology 2000;47:927-31.
5. Klempnauer J, Ridder GJ, Werner M, et al. What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34.
6. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single center experience. Ann Surg 1996;224:628-38.
7. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990;14:535-43.
8. Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: A review and commentary. Ann Surg Oncol 2000;7:55-66.
9. Launois B, Reding R, Lebeau G, et al. Surgery for hilar cholangiocarcinoma: French experience in collective survey of 552 extrahepatic bile duct cancers. J Hepato-Biliary-Pancreatic Surgery 2000;7:128-34.
10. Yeh TS, Yan YY, Tseng JH, et al. Malignant perihilar biliary obstruction: Magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol 2000;95:432-40.
11. Hann LE, Winston CB, Brown KT, et al. Diagnostic imaging approaches and relationship in hepatobiliary cancer staging and therapy. Sem Surg Oncol 2000;19:115.
12. Kluge R, Schmidt F, Caca K, et al. Positron Emission tomography with 18Fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;1029-35.
13. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. FDG-PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Comm 2001;22:1277-85.
14. Foutch PG. Diagnosis of cancer by cytologic methods performed during ERCP. Gastrointest Endosc 1994;40:249-52.
15. de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 2002;56:720-30.
16. Jailwala J, Fogel EL, Sherman S, et al. Triple tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000;51:383-90.
17. Mansfield JC, Griffin SM, Wadehra V, et al. A prospective evaluation of cytology from biliary strictures. Gut 1997;49:671-7.
18. Glasbrenner B, Ardan M, Boeck W, et al. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999;31:712-7.
19. Gerhards MV, Vos P, Van Gulik TM, et al. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 2001;88:48-51.
20. Vauthey JN, Blumgart LH. Recent advances in the management of cholangio-carcinomas. Sem Liver Dis 1994;14:109-14.
21. Verbeek PC, van Leeuwen DJ, de Witt LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112:866-71.
22. Wetter LA, Ring EJ, Pellegrini CA, et al. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991;161:57-63.
23. Fritscher-Ravens A, Broering DC, Sriram PVJ, et al. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: A case series. Gastrointest Endosc 2000;52:534-40.
24. Bismuth H, Nakache R, Diamond T. Management strategies in resection of hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
25. Atay Z. The reliability of cytodiagnosis in determining malignancy histogenetic tumor type. In: Nakhosteen JA, Maassen W, eds., Bronchology: Research, diagnostic and therapeutic aspects. Boston: Martinus Nijhoff Publishers, 1981:37-42.
26. Pitt HA, Dooley WC, Yeo CJ, et al. Malignancies of the biliary tree. Curr Probl Surg 1995;32:1-90.
27. Verbeek PC, Van der Heyde MN, Ramsoekh T, et al. Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma. Semin Liver Dis 1990;10(2):142-4.
28. Chapman WV, Sharp KW, Weaver F, et al. Tumor seeding from percutaneous biliary catheters. Ann Surg 1989;209:708-15.